Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the third quarter of 2023.
- The company reported a net loss of $227 million for the third quarter, compared to a profit of $141 million a year earlier
- On a per-share basis, it was a loss of $1.26 for the March quarter vs. earnings of $0.78 in the year-ago quarter
- The adjusted net loss was $0.09 per share, compared to net income of $1.04 per share in Q3 2022
- Third-quarter net revenue decreased 19% year-over-year to $1.04 billion
- Q3 adjusted EBITDA came in at $105 million, which is down 69% from the corresponding period of 2022
- For fiscal 2023, the management expects net revenue to be in the range of $4.225 billion to $4.325 billion
- The forecast for full-year adjusted net income is $169-210 million
Most Popular
Deere & Company (DE) Q2 2025 earnings fall on lower revenues
The Deere & Company (NYSE: DE), a leading manufacturer of agricultural and construction equipment, on Thursday reported a double-digit fall in revenue and net income for the second quarter of 2025. The company's
Key metrics from Alibaba Group’s (BABA) Q4 2025 earnings results
Alibaba Group Holding Limited (NYSE: BABA) reported its fourth quarter 2025 earnings results today. Revenue was $32.5 billion, up 7% year-over-year. Net income attributable to ordinary shareholders was $1.70 billion.
WMT Earnings: All you need to know about Walmart’s Q1 2026 earnings results
Walmart Inc. (NYSE: WMT) reported its first quarter 2026 earnings results today. Total revenue of $165.6 billion was up 2.5%, or 4% in constant currency, year-over-year. Net sales of $164
